This content is machine translated Idiopathic pulmonary fibrosis Change of therapy often useful Two antifibrotic drugs are currently available for the drug therapy of idiopathic pulmonary fibrosis (IPF): Pirfenidone and the tyrosine kinase inhibitor nintedanib. Therapy intolerances are rare, but do occur. However,…
